Together, these policies signal a new era of pricing accountability and regulatory oversight, with significant implications for drug development strategies, market access, and patient affordability.

Eisai has scaled down its sales expectations for Alzheimer's disease drug Leqembi after sluggish sales growth in the first half of the current fiscal year.

Aurora Beacon-News: Your source for Aurora, Illinois news, events, crime reports, community announcements, photos, high school sports and school district news.